by The global live cell imaging market size was estimated to be around US$ 2.6 billion in 2022. It is projected to reach US$ 5.74 billion by 2032, indicating a CAGR of 8.3% from 2023 to 2032.
Key Takeaways
- North America captured more than 39% of revenue share in 2022.
- Asia-Pacific is expected to expand at the fastest CAGR during the forecast period.
- By Product, the equipment segment has held the biggest revenue share of 43% in 2022.
- By Product, the software segment is anticipated to grow at a remarkable CAGR of 12.8% during the projected period.
- By Application, the cell biology segment held the maximum market share of 29% in 2022.
- By Application, the developmental biology segment is projected to expand at the fastest CAGR over the projected period.
- By Technology, the fluorescence resonance energy transfer segment contributed more than 37% of revenue share in 2022.
- By Technology, the high content screening (HCS) segment is anticipated to grow at the fastest CAGR over the projected period.
Overview:
The Live Cell Imaging market is experiencing significant growth driven by advancements in imaging technologies and an increasing focus on understanding cellular dynamics in real-time. Live cell imaging involves the visualization of living cells using various microscopy techniques, providing researchers with valuable insights into cellular processes and behavior. This technology has become indispensable in fields like cell biology, drug discovery, and developmental biology.
Get a Sample: https://www.precedenceresearch.com/sample/3423
Live Cell Imaging Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 8.3% |
| Market Size in 2023 | USD 2.8 Billion |
| Market Size by 2032 | USD 5.74 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Application, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Vaccine Contract Manufacturing Market Size To Attain USD 8.92 Billion By 2032
Growth Factors:
Several key factors contribute to the robust growth of the Live Cell Imaging market. Technological innovations, such as the development of high-resolution imaging systems and sophisticated analysis software, enhance the precision and depth of cellular observations. The rising demand for personalized medicine and the need for better understanding of diseases at the cellular level further propel the market. Additionally, collaborations between academic institutions, pharmaceutical companies, and imaging equipment manufacturers foster research and development, driving the expansion of the Live Cell Imaging market.
Region:
The Live Cell Imaging market exhibits a global presence with notable regional variations. North America dominates the market share due to a well-established research infrastructure, substantial investments in healthcare, and a high adoption rate of advanced imaging technologies. Europe follows closely, benefiting from strong academic and industrial collaborations.
Asia-Pacific is emerging as a significant player, with increasing investments in life sciences research and a growing awareness of the importance of live cell imaging in biomedical studies. The market in these regions is characterized by a dynamic interplay of technological advancements, research funding, and the evolving healthcare landscape.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Live Cell Imaging Market Players
- Carl Zeiss AG
- Nikon Corporation
- Leica Microsystems GmbH
- Thermo Fisher Scientific Inc.
- Olympus Corporation
- GE Healthcare
- PerkinElmer, Inc.
- Molecular Devices LLC
- Bruker Corporation
- Becton, Dickinson and Company (BD)
- Andor Technology
- Yokogawa Electric Corporation
- CYTOO S.A.
- Logos Biosystems, Inc.
- NanoEnTek Inc.
Segments Covered in the Report
By Product
- Equipment
- Consumable
- Software
By Application
- Cell Biology
- Developmental Biology
- Stem Cell & Drug Discovery
- Others
By Technology
- Time-lapse Microscopy
- Fluorescence recovery after photobleaching (FRAP)
- Fluorescence resonance energy transfer (FRET)
- High content screening (HCS)
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Live Cell Imaging Market
5.1. COVID-19 Landscape: Live Cell Imaging Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Live Cell Imaging Market, By Product
8.1. Live Cell Imaging Market, by Product, 2023-2032
8.1.1 Equipment
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Consumable
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Software
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Live Cell Imaging Market, By Application
9.1. Live Cell Imaging Market, by Application, 2023-2032
9.1.1. Cell Biology
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Developmental Biology
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Stem Cell & Drug Discovery
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Live Cell Imaging Market, By Technology
10.1. Live Cell Imaging Market, by Technology, 2023-2032
10.1.1. Time-lapse Microscopy
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Fluorescence recovery after photobleaching (FRAP)
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Fluorescence resonance energy transfer (FRET)
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. High content screening (HCS)
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Live Cell Imaging Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by Technology (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Technology (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Technology (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by Technology (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Technology (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Technology (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Technology (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Technology (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by Technology (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Technology (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Technology (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Technology (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Technology (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by Technology (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Technology (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Technology (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Technology (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Technology (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by Technology (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Technology (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Technology (2020-2032)
Chapter 12. Company Profiles
12.1. Carl Zeiss AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Nikon Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Leica Microsystems GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Thermo Fisher Scientific Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Olympus Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. PerkinElmer, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Molecular Devices LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bruker Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Becton, Dickinson and Company (BD)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
